CRVO
CRVO clinical trials: CervoMed Inc.
Every trial on ClinicalTrials.gov where CervoMed Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 0
- As lead sponsor
- 4
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CRVO on the catalyst calendar · CRVO registry changes
- Primary completion Sep 23, 2026ActualPhase 2NCT06987643A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic StrokeEIP Pharma Inc · Moderate to Severe Acute Ischaemic StrokeCompletedCRVOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 29, 2025ActualPhase 2NCT05869669RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy BodiesEIP Pharma Inc · Dementia With Lewy BodiesCompletedCRVOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 11, 2026ActualPhase 2NCT06815965A Clinical Study of Neflamapimod in Patients With Dementia With Lewy BodiesEIP Pharma Inc · Dementia With Lewy Bodies (DLB)CompletedCRVOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2026Sponsor estimatePhase 2NCT07033481Clinical Study of Neflamapimod in Patients With Primary Progressive AphasiaEIP Pharma Inc · Nonfluent Variant Primary Progressive Aphasia (nfvPPA)Active, not recruitingCRVOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner